SynBiotic SE Company Description

SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.

It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and cannabis products for recreational use under the Hempamed, Princess Stardust, The Hempany, and Hempamed Rx brand names.

The company was formerly known as Ledgertech SE and changed its name to SynBiotic SE. SynBiotic SE was incorporated in 2024 and is based in Munich, Germany.

SynBiotic SE

Country	Germany
Founded	2024
Industry	Pharmaceutical Preparations
Employees	55
CEO	Daniel Kruse

Contact Details

Address: Barer Strasse 7 Munich, 80333 Germany
Website	synbiotic.com

Stock Details

Ticker Symbol	SBX
Exchange	Frankfurt Stock Exchange
Fiscal Year	January - December
Reporting Currency	EUR
SIC Code	2834

Key Executives

Name	Position
Daniel Kruse	Chief Executive Officer